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ABSTRACT OF THESIS

COPLANAR PCB77 AND ANGII INDUCED VASCULAR DISORDERS
Previous studies demonstrated that coplanar PCBs promote inflammation by
release of pro-inflammatory cytokines like TNF, MCP-1, and VCAM-1 from
endothelial cells as well as adipocytes. Also these PCBs at small doses may
contribute to the development of obesity by inducing adipocyte differentiation.
Obesity is a known risk factor that promotes cardiovascular disorders like
atherosclerosis and AAAs. Evidence shows Ang II, a component of the RAS,
leads to the formation of atherosclerosis and AAAs in both normal as well as
hyperlipidemic mice. Earlier studies in our laboratory have also shown that
coplanar PCB-77 promotes atherosclerotic lesion formation in ApoE-/- mice. The
purpose of this study was to define the effects of PCB77 on Ang II induced
vascular diseases like atherosclerosis and AAAs. Two different hyperlipidemic
mouse models, which require different diets to get atherosclerosis, the ApoE
deficient mice (ApoE-/-) requiring the normal mouse diet (Chow diet) and the Low
Density Lipoprotein Receptor deficient mice (LDLr-/-) requiring the Western diet,
were used for this study as both are susceptible to Ang II induced vascular
disorders. The timing of PCB administration was also studied in LDLr-/- mice to
see the profound effects of PCB77 on atherosclerosis and AAAs.

Keywords: Polychlorinated biphenyl; angiotensin II; hyperlipidemic mice;
aneurysm; atherosclerosis
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CHAPTER 1: POLYCHLORINATED BIPHENYLS

1.1 INTRODUCTION
Polychlorinated Biphenyls (PCBs) (Figure 1.1) which are also known as
Persistent Organic Pollutants are a major environmental and public health
concern in the United States. Exposure to such hazardous chemicals can lead to
compromised health and cause a number of pathologies like cardiovascular
disorders, cancer, diabetes etc. PCBs were produced and sold in US as highly
stable organic soluble industrial compounds and played a predominant role as
dielectric, heat transfer fluids, plasticizers, wax extenders and flame retardants
(Carpenter, 2006). They were highly functional due to their properties like high
heat and electric resistance, non-solubility in water and high lipophillicity. Even
though these compounds were banned in the US in 1977, due to their highly
persistent nature they are yet found in all parts of the ecosystem. With an
octanol: water coefficient of 104, PCBs are considered highly hydrophobic and
hence lipophilic. The lipophillicity increases with increasing degrees of
1

chlorination. Theoretically 209 congeners are possible but only 130 have been
identified in commercial mixtures. Also being persistent they can be altered by
physical and biological processes. They are vulnerable to both anaerobic and
aerobic degradation and can be metabolized in the body (McFarland et al, 1989)

Figure 1.1 Structure and positional nomenclature (a) and numbering (b) for
biphenyl.
(McFarland et al, 1989).
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1.2 PCB TOXICITY
PCBs are lipophilic substances to which can enter the human body through
ingesting animal fats, inhalation, or dermal contact. Exposure to PCBs can
lead to suppression of the immune system, due to which there is increased
risk of acquiring several human diseases (Smits et al, 2002). Both orthosubstituted and coplanar (dioxin-like) congeners act as tumor promoters that
excentuate the effects of other carcinogenic substances. (Knerr et al, 2006)
PCB exposure during fetal and early life can cause reduction in IQ and
behavior alteration and also cause developmental neurotoxicity (Seegal et al,
2005) The PCBs have also known to alter thyroid and reproductive function in
both males and females. Also an increase in the risk of developing
cardiovascular, liver disease and diabetes was seen. Women exposed to
PCBs are at high risk of giving birth to infants of low birth weight
(Baibergenova et al, 2003). These infants are at high lifetime risk for several
diseases. As knowledge of their toxic effects has grown faster than

3

environmental levels have declined, PCBs remain dangerous contaminants
(Carpenter, 2006)

1.3 CLASSIFICATION OF PCBs
The chemical formula for PCBs is C12H

10-n

Cln, n ranges from 1-10. (Air Quality

guidelines for Europe)

There are 2 types of classification-

1)

Structural- Under the structural classification PCBs can be coplanar or

non-coplanar. In coplanar PCBs the chlorine atoms are in the para or 0-4 meta
positions. PCBs which are substituted in the para and meta positions will exhibit
maximum coplanar conformational character. Figure 1.2 shows the structures of
all the 4,4'-dichlorobiphenyl-substituted PCBs and represents a subset of the
group of coplanar compounds.(Safe S et al, 1985)

4

Figure 1.2 Coplanar PCB congeners substituted at both para and 0-4 meta
positions
(Safe S et al, 1985; Carpenter, 2006).

In the non-coplanar PCBs the chlorine atoms are either mono-ortho substituted
(Fig 1.3) or di-ortho substituted (Fig1.4). The chlorine in the ortho position causes
stearic differences between the chlorine and hydrogen atoms as a result of which
there is a shift in the planar structure (Safe S et al, 1985)

5

Figure 1.3 Mono-substituted PCB
(Safe S et al, 1985)

Figure 1.4 - Di-ortho substituted PCB
(Safe S et al, 1985)
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Table 1.1 shows the various possible positions of chlorine atoms on the 209
congeners.( Air Quality guidelines for Europe) The simplest structure being the
presence of 1 chlorine atom at a given time and the most complex being the
presence of 9 chlorine atoms.

Table 1.1 IUPAC numbers and chlorine atom positions of all PCB
(Air Quality guidelines for Europe)
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2) Functional Classification-

According to their functions PCBs can be classified as Dioxin like and Non Dioxin
like PCBs.
Dioxin like PCBs resembles weak dioxins. 2,3,7,8 TCDD is the most toxic
polychlorinated dioxin congener. They are usually coplanar and mono-ortho
substituted in structure and are activators of the Aryl Hydrocarbon Receptor
(AHR) similar to the dioxins. Many of the toxic effects are similar to TCDD. Non
Dioxin like PCBs are either weak AHR ligands or they do not bind the AHR but to
some other receptors like the CAR. These are usually the ortho-substituted PCB
configurations (Safe S et al, 1985)

8

1.4 TOXIC EQUIVALENT FACTORS- RISK ASSESSMENT OF PCBs

PCBs are usually present in mixtures along with Polychlorinated dibenzos-pdioxins (PCDDs) and dibenzofurane (PCDFs) as persistent pollutants. PCDDs,
PCDFs and PCBs have been shown to cause toxic responses similar to 2,3,7,8tetrachlorodibenzo-pdioxin (TCDD), the most potent congener within these
groups of compounds ( Van den Berg et al, 1998). All these compounds are
present in environmental and biological samples in varying concentrations.
These differences are caused by environmental degradation as a result of which
these mixtures change spatially and temporally into the environment and are very
different from the technical mixtures originally released into the environment.
Because of the complex nature of these compounds, it is difficult to evaluate the
risk to humans, fish, birds and wildlife. Hence for this purpose the concept of
Toxic Equivalent Factors was introduced by the European Centre of
Environmental Health of the World Health Organization (ECEHWHO) and the
International Programme on Chemical Safety (IPCS) to assess the risk and for
9

regulatory control of exposure to these mixtures (Table 1.2) To apply the concept
of TEF all compounds need to follow a common mechanism of action. A number
of studies show that many of these compounds act via binding to the AHR as the
initial step. When applying the TEF concept, the toxicity of these compounds
relative to that of 2,3,7,8-TCDD is determined on the basis of available in vivo
and in vitro data (Safe S et al,1985, Van den Berg et al, 1998)
Table 1.2 World Health Organization TEFs for humans, mammals and birds.
(Van den Berg et al, 1998)

1.5 TISSUE DISTRIBUTION OF PCBs
PCBs are fat soluble and highly lipophilic which is evident from their octanol:
water coefficients of ≥ 104. As a result of this high lipophillicity, PCBs are known
10

to accumulate more in lipid than non-lipid materials wherein their presence is
almost negligible. In a study by Kodavanti and coworkers congener-specific
distribution of PCBs was determined after chronic exposure in rats (Kodavanti et
al, 1998). Rats were treated with a mixture of Aroclor 1254 in corn oil five times
a week for 4 weeks and showed highest accumulation of PCBs (parts per million)
in fat (551µg/g) followed by in liver (38.27 µg/g). Similar results have also been
seen in other studies for specific PCB congeners like PCB 153 (Wyss et al, 1986)
and PCB 180 (Koss et al, 1993). Also due to slightly different octanol: water
coefficients of various congeners (Table 1.3) their degree of lipophillicity may
differ.

11

Table 1.3 Partition Coefficients of Coplanar and Non-Coplanar PCBs
Kow > 6 describes an extremely hydrophobic compound
Congener Coplanar/Noncoplanar Log octanol: water coefficients
PCB77

Coplanar, Non-ortho

5.9

PCB153

Non-coplanar

7.0

TCDD

7.5

In a study previously conducted in our lab, Arsenescu et al. (Arsenescu et al,
2008) showed that adipocyte differentiation and proinflammatory adipokine
expression were induced by PCB-77 but not by PCB-153 in 3T3-L1
adipocytes. A lack of effect of PCB-153 may have resulted from greater
sequestration of this more-lipophilic PCB in the triacylglycerol droplet of the
adipocyte, leaving less PCB-153 available to act at adipocyte target proteins
and also due to other alternate mechanisms like differences in receptors for
their action.

12

CHAPTER 2: ARYL HYDROCARBON RECEPTOR

2.1 INTRODUCTION
PCBs are a huge family of chemicals, consisting of 209 possible congeners, only
small parts of which resemble the dioxins. A number of multiple, overlapping
structural classes of PCBs exist, but PCBs characteristically are present as
mixtures, and never are present in the absence of PCBs which are dioxin like in
the encompassing environment (Van den Berg et al, 1998). Likely, dioxins like
TCDD and PCBs are rarely found in the absence of one another. Individual PCBs
are known to have their own intrinsic toxicities, and can also interact with dioxins
and other PCB congeners producing additive, synergistic, and/or antagonistic
reactions, granting high variability to the activity of the PCB mixtures (White et al,
2009).

The mechanism of action by which dioxins and dioxin like PCBs produce their
biochemical toxic effect is via the activation of the AHR.(Klinge et al, 1999) AHR
is a basic helix-loop-helix transcription factor which is activated by ligands like
13

dioxins, PCBs etc. It belongs to the PER-ARNT-SIM (PAS) superfamily of
transcription factors (Petrulis et al, 2002). The AHR is a highly conserved
transcription factor across vertebrate species, and its presence has also been
identified in invertebrates, such as C. elegans and Drosophila species. (Hahn et
al, 1997)

2.2 MECHANISM OF ACTION
AHR is present in the cell in a non-ligand state. AHR exists as a complex in the
cytosol along with chaperone proteins, which are two molecules of heat shock
protein (Hsp) 90, and a molecule each of prostaglandin E synthase 3 (p23) and
immunophilin-like protein hepatitis B virus X-associated protein 2 (XAP2, also
known as AIP or ARA9) (Figure 2.1) (Petrulis et al, 2002). Toxins like dioxin and
similar compounds enter the cell by diffusion. Activation of AHR by the ligand
results in the disruption of the AHR complex in the cytosol causing dissociation of
one Hsp 90 molecule and all the p23 and XAP2 molecules. The AHR-TCDD
complex travels into the nucleus. Once in the nucleus, AHR must heterodimerize

14

with the AHR Nuclear Translocator (ARNT), at their respective PAS domains,
releasing the remainder molecule of Hsp 90, after which transcription occurs.
AHR-TCDD-ARNT complex then binds to the DNA at dioxin response elements
(DRE; or xenobiotic response elements, XRE) in the promoter regions of target
genes. This process depends upon the presence of co-activators or corepressors and transcription may proceed. An assembly of coactivators and
general transcription factors, including p300, SRC-1, p/CIP and transcription
factor IIB, then interact with gene promoters and potentiate the expression of
target loci (Harkinson, 2005). AHR is also believed to interact with other key
regulatory molecules including nuclear steroid receptors and cell cycle control
molecules. Many of the metabolic enzymes show altered expression after TCDD
exposure. These are directly controlled by the actions of the AHR-TCDD-ARNT
complex on upstream DREs (Puga et al, 2009)

15

Figure 2.1 Model of ligand-dependent and -independent movement of the AHR
between the cytoplasm and the nucleus
(Petrulis et al, 2002).
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2.3 ROLES OF AHR
1. Physiological and Developmental Role of the AHR

A number of studies show evidence that strengthens the idea that AHR plays a
dual role in normal biology as follows-

a. Role as a mediator of an adaptive response to xenobiotics.

b. Role as a mediator of normal embryonic development and adult physiology.

The AHR and all associated members of the signaling complex are expressed by
both humans and the various laboratory species studied. The human cell and
tissue culture studies have demonstrated human responsiveness to dioxins
similar to that observed in other species (DeVito et al, 1995). In addition,
exposed human populations have exhibited measurable biochemical responses,
in regard to genes involved in drug metabolism as well as other known target
genes for AHR and adverse health effects have been extensively observed in
highly exposed populations.(White et al, 2009)

17

The PAS family of regulatory proteins are often known as “biological sensors”
and being a part of the PAS superfamily the AHR is believed to play key roles in
development, aging, hypoxia, and circadian rhythms ( Petrulis et al, 2002; Puga
et al, 2009).

Different labs studying the physiology and development of AHR null or knockout
mice show developmental irregularities and pathological endpoints that are
induced when AHR signaling is interfered by receptor deletion. For example a
40-50% neonatal lethality rate, inflammation of the bile ducts and an 80%
depletion of splenic lymphocytes is reported for 3-week old AHR null mice
(Fernandez-Salguero et al, 1995).

The AHR knockout mice also present a phenotype which is vascular in nature,
called patent Ductus Venosus (DV), which is a fetal porto-caval shunt of the
developing liver that normally closes immediately after birth (Lahvis et al, 2000).
Due to failure in closing of this shunt the mutant’s show an abnormal hepatic
blood supply and altered arrangement of small molecules which then requires
18

hepatic clearance. These AHR mutant mice also demonstrate the presence of
the hyaloid artery and an aberrant network of limbal vasculature in the
developing eye. Similar to the DV, the hyaloid artery also exhibits a second fetal
vascular structure that normally is absent after birth, yet is seen in the eyes of
adult AHR null mice ( Lahvis et al, 2000, Walliser et al, 2004).

Studies involving gene targeting, to generate AHR hypomorphic mice with
decreased levels of AHR, had similar high frequency of DV as seen in the AHR
null mice (Walliser et al, 2004). Exposure of these hypomorphic mice to a potent
AHR ligand like TCDD between embryonic days E12.5-E18.5 led to the complete
resolution of the DV and the maturation of a normal-sized liver by adulthood.
From this study it could be concluded that endogenous agonist activates the
AHR to regulate vascular development during normal ontogeny (Lahvis et al,
2000).

19

2. Toxic Response

Dioxin and dioxin like compounds bind the AHR, disrupting its endogenous
function. That is, the physiological activator of the AHR likely induces rapid on/off
signaling through the receptor. Dioxins, however, are believed to induce toxicity
through the persistent activation of the AHR, thereby preventing the AHR from
functioning in the maintenance of homeostasis.

Some toxic responses produced by TCDD causing inflammation appear to arise
via a non-genomic pathway (Figure 2.2). This pathway is brought about by
ligand-activation of AHR, but doesn’t require nuclear translocation or for the
dimerization partner of AHR, ARNT, thus it also doesn’t require binding to the
DRE followed by transcription, both very important components of the classical
pathway (Li et al, 2008). In the ligand activated AHR non-genomic pathway
TCDD elicits an inflammatory response by stimulating cascading events which
involves rapid increase in intracellular Ca(2+) levels, activation of phospholipase
A2 in the cytosol (cPLA2) and Cox-2 activation. (Matsumura et al, 2009).
20

Figure 2.2: Toxic response by TCDD by non-genomic pathway
(Li et al, 2008)
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2.4 ACTIVATORS OF AHR
Endogenous Ligands of particular interest are those that are known to be
endogenously synthesized in higher organisms. Figure 2.3 enlists candidate
endogenous AHR ligands that have been isolated from mammalian tissues.

Some of the dietary compounds have also been found to activate the AHR and
play an important role as a physiologically relevant activator of this receptor
(Figure 2.4).

Exogenous Ligands include the halogenated-dibenzo-p-dioxins, -dibenzofurans, azo(xy)benzenes, -naphthalenes, polychlorinated biphenyls and polycyclic
aromatic hydrocarbons comprise a family of important, structurally related AHR
agonists.(Figure 2.5)

22

Figure 2.3 Endogenous AHR ligands from mammalian tissues
(Denison et al, 2003)

Figure 2.4 Dietary Compounds that activate AHR
(Denison et al, 2003)
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Figure 2.5 Exogenous AHR ligands
(Denison et al, 2003)
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CHAPTER 3: PCB AND INFLAMMATION
Several studies show that Persistent Organic Pollutants like dioxins and coplanar
PCBs which are AHR agonists may promote inflammation and interrupt normal
function of various cell types like endothelial cells (Toborek et al, 1995) and
adipocytes (Arsenescu et al, 2008). Coplanar PCBs may affect the normal
functions of vascular endothelial cells by inducing pathways signaling oxidative
stress and initiating proinflammatory events such as increased expression of
CYP1A1 gene, VCAM-1, NF-kappaB which play an important role in the
pathology of atherosclerosis and cardiovascular disease (Toborek et al, 1995;
Hennig et al, 2002). In separate experiments it was also seen that coplanar PCB
77 caused upregulation of MCP-1 expression by endothelial cells and that this
effect is mediated by AHR, as well as p38 and JNK MAPK pathways (Choi et al,
2003).

Hennig and group also showed that dietary fat in combination with PCBs caused
ellicitation of aberrant gene patterns associated with dysregulated lipid
metabolism (Arzuaga et al, 2009 ). The microarray data from this study showed
25

that coplanar PCB 77 caused disruption of dietary fatty acid induced changes in
gene expression. In addition to the interactive effects of dietary fat and PCB
exposure on genes associated with triacylglycerol synthesis and cholesterol/bile
acid metabolism, dysfunction of several genes associated with fatty acid
metabolism (both synthetic and oxidative pathways), i.e., genes that are also
regulated by PPARs was also observed. For example, acyl-coenzyme A
dehydrogenase-medium chain (Acadm) is a mitochondrial enzyme that catalyzes
the initial step in fatty acid metabolism. All these altered gene findings provide an
indication of the molecular mechanism supporting the experimental and
epidemiological evidence that exposure to persistent organic pollutants are
significant risk factors for hepatic and cardiovascular disease (Choi et al, 2003).

Coplanar PCBs which are AHR agonists are responsible for the observed
increase in inflammation (Slim et al, 1999; Hennig et al, 2002; Arzuaga et al,
2007). Adipocytes also express AHR (Shimba et al, 1998). Hence if adipocytes
release inflammatory cytokines it is possible that adipocytes would promote
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obesity and obesity related cardiovascular disorders (Mullerova et al, 2006).
When 3T3-L1 adipocytes were treated with coplanar PCB 77, it increased the
expression of proinflammatory adipokines like TNF-α, MCP-1, KC-1 and CD36
and

also

of

adipocyte

differentiation

factors

like

PPAR¥,

aP2

and

angiotensinogen (Arsenescu et al, 2008), suggesting that coplanar PCB77
promoted obesity and obesity related inflammatory disorders like cardiovascular
diseases. In vivo experiments showed that when ApoE-/- mice were treated with
either PCB 77 or vehicle, the treatment animals showed significant increase in
total serum cholesterol especially the VLDL particle and increased Oil Red O
staining in the aortic sections showing an increase in atherosclerosis in PCB
treated animals (Arsenescu et al, 2008)
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CHAPTER 4: ANG II INDUCED VASCULAR DISORDERS
The Renin Angiotensin System (RAS) has been implicated in cardiovascular
disorders like hypertension, atherosclerosis and aortic abdominal aneurysms
(AAA) (Hollenberg, 2000; Grote et al, 2004; Lu et al, 2008). There is substantial
evidence that suggests that Ang II plays a pivotal role in the atherogenic process.

4.1 ANGII AND ATHEROSCLEROSIS
Cardiovascular disorders are the most common cause of morbidity and mortality
in developed countries (Grote et al, 2004). Atherosclerosis is the underlying
cause for ischemic heart disease. Ang II may lead to the acceleration of the
atherogenic process by a number of possible mechanisms (Singh et al, 2003).
Earlier studies showed Ang II caused elevations in blood pressure to indirectly
lead to formation of atherosclerosis (Atlas, 2007), but current studies do not
support this evidence (Gupte et al., 2009). Studies have shown profound
increases in atherosclerotic lesion development despite no increase in arterial
blood pressure measured by tail cuff and catheter measurements from the
carotid artery on anesthetized mice (Daugherty et al, 2000). Norepinephrine
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infusion also caused elevation in systolic blood pressure comparable to Ang II
infusion in ApoE deficient mice, which had minimal effect on atherosclerosis
(Weiss et al, 2001) (Cassis et al., 2009). Systolic blood pressure was measured
by a computerized tail cuff system during treatment and at the end of each
experiment. Similar findings were demonstrated in our lab earlier for Ang IIinduced AAAs (Cassis et al, 2009). Infusion of Ang II and norepinephrine caused
equivalent blood pressure increases in LDLr-/- and ApoE-/- mouse models, but
only Ang II infusion caused AAA formation. Moreover, infusion of Ang II at a rate
of 500 ng·kg−1·min−1 did not significantly elevate blood pressure but resulted in
a 50% AAA incidence. Also reduction of Ang II-induced increases in blood
pressure by concurrent administration of hydralazine did not influence
development of AAAs. Hence increases in blood pressure from infusion of Ang II
do not significantly contribute to formation of AAAs.
In a pivotal study by Daugherty and group when Ang II was infused in LDLR-/and ApoE-/- mice fed a high fat and cholesterol-containing diet; there was
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accelerated formation of atherosclerotic lesions (Daugherty et al, 1999; 2000). An
Ang II infusion of only 28 days led to an increase in the area of discernible
lesions in the aortic intima. A more prolonged infusion of 8 weeks caused a more
profound formation of atherosclerotic lesions in ApoE-/- mice fed on high fat,
cholesterol and cholate diet (Weiss et al, 2001).
The infusion rate of Ang II is also very important. An infusion rate of
500ng/kg/min in C57BL/6 mice caused no observable changes in arterial blood
pressure, body weight, and cardiac hypertrophy (Cassis et al, 2004). Similarly the
same infusion rate as well as a higher infusion rate of 1000ng/kg/min in ApoE-/mice did not produce any changes in arterial blood pressure, serum cholesterol
concentrations or distribution of lipoprotein cholesterol (Daugherty et al, 2000),
but these infusion rates promoted an increased severity of aortic atherosclerotic
lesions.
Hypercholesterolemia caused by aberrant cholesterol metabolism has generally
been considered as an independent mechanism in the development of severe
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atherosclerosis. Some possible hypercholesterolemia-induced mechanisms are
related to the RAS including increased AT1-receptor expression, increased
responsiveness to Ang II and increased synthesis of angiotensin peptides
(Daugherty et al, 2004).
A direct role of Ang II in atherosclerotic disease can be inferred from human trials
(Heart Outcomes Prevention Evaluation Study Investigators, 2000) in which
angiotensin converting enzyme I (ACE I) inhibition by ramipril reduced
cardiovascular events in people with coronary artery disease without major
changes on blood pressure. Patients treated with ramipril exhibited reduced rates
of death, myocardial infarction, stroke, coronary revascularization, cardiac arrest,
and heart failure. A very small part of the benefit could be credited to a reduction
in blood pressure, as the mean reduction in blood pressure with treatment was
extremely small (3/2 mm Hg).
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4.2 ANG II INDUCED ABDOMINAL AORTIC ANEURYSMS.
Abdominal aortic aneurysms (AAAs) are progressive dilations of the infrarenal
aorta that can rupture when increasing in size, commonly leading to death
(Diehm et al., 2005). AAAs affects 1.1 million American people (Lim et al., 2011;
Nordon et al., 2011), being primarily present in males over 60 years of age. AAAs
account for 2% of all deaths and are the tenth most common cause of mortality
(Natl Vital Stat Rep). As AAAs progress in size, the risk of rupture increases. The
only treatment option to prevent rupture of AAAs is surgical, either by open repair
or endovascular approaches.
In addition to these well-described effects on blood pressure and atherosclerosis
it is becoming increasingly evident that the RAS contributes to the development
of AAAs. Pivotal studies demonstrated that a 1 month infusion of Ang II to
hypercholesterolemic mice resulted in AAAs in 80-100% of male mice
(Daugherty et al, 2000). These aneurysms are observed in the suprarenal area of
mouse aorta, whereas in humans AAAs form in the infrarenal region of
abdominal aortas. The differing localization could reflect a discrepancy between
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AAA formation in humans and mice because of hemodynamic differences.
Humans being biped and mice are quadruped; it may be possible that
hemodynamic forces would differ between these two species. This formation of
Ang II induced AAA in the suprarenal region of the abdominal aorta is seen
consistently in both LDLR-/- and ApoE-/- mice.
Saraff et al in 2003 conducted a study to find out the temporal sequence of
events in Ang II-induced AAAs to provide mechanistic insight into AAA initiation
and maturation. The earliest changes were noted at 1-4 days after Ang II infusion
where there was medial accumulation of macrophages in the region that
develops aneurysms along with disruption of elastin fibers. There is a clearly
defined medial dissection and approximately 10% of male mice died between 4
and 10 days by a vascular hematoma that was grossly observed in the majority
of the mice. In the mice that survived there was a development of thrombi which
caused

an

inflammatory

reaction

that

prominently

involved

infiltrating

macrophages. These macrophages were present in the thrombi. After 14 days
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the thrombi is replaced by extracellular matrix with increased macrophage
deposition. T and B lymphocytes are also seen in this area. A remodeling of the
artery follows and after a period of time the enlarged artery is completely reendothelialized and the endothelium was demonstrable adjacent to the original
medial layer. This remodeling is permanent and all three arterial layers are
present. There was no evidence that atherosclerosis affects the formation of
AAA’s. Atherosclerotic lesions marked with lipid laden macrophages were
detected after only 28 days of Ang II infusion. AAAs also form from Ang II
infusion in normolipidemic C57BL/6 mice (Deng et al 2003), though the incidence
is much less than in hyperlipidemic mice.
Gender also plays an important role in the incidence of AAA’s. Males are more
prone to get AAA’s than females in both humans and mice. (Manning et al 2002,
Henriques et al, 2004). The gender difference is due to endogenous steroid
hormones like androgen. It is also seen that male sex hormones positively
regulate AT1aR expression in a regional-specific manner to promote Ang II–
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induced AAAs in both male and female ApoE-/- mice.(Henriques et al, 2008)
Another study also showed that estrogen administration reduced the incidence
and severity of AAA. (Martin-McNuty et al 2003).
The receptor subtype also has a significant role to play for Ang II to exert its
effect. Administration of an AT1 receptor antagonist, losartan, ablated the
formation of Ang II induced AAAs proving that Ang II exerts its pathophysiological
effects through AT1 receptors. (Daugherty et al 2001) Amongst all the RAS
components like renin, prorenin/renin receptor, angiotensinogen, AT1- and AT2
receptors, cathepsin D, cathepsin G and chymase, the expression of all RAS
components are upregulated except AT2 receptors in AAAs (Kaschina et al,
2009). Activation of AT2 receptors by agonists decreases the effects of AT1
receptor agonists. Coadministration of the AT2 receptor antagonist PD123319
greatly enhanced the development of AAAs (Daugherty et al. 2001).
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The matrix metalloproteinase (MMPs) enzymes play a pivotal role in the
pathogenesis of AAAs. The frequently detected MMPs in the aneurysmal tissue
are MMP-2 and MMP-9 (Goodall et al. 2001; Longo et al. 2002; Pyo et al. 2000).
Administration of doxycycline, an inhibitor of MMPs, reduced both the incidence
and the severity of AAAs and are suggested to have anti AAA properties in
humans (Manning et al, 2003; Thompson and Baxter 1999).
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STATEMENT OF PROBLEM
Obesity is a well-known risk factor that causes cardiovascular disorders like
atherosclerosis and AAAs. PCBs because of their lipophilic nature are
sequestered in the fat depots of obese people (Kodavanti et al,1998). PCBs are
also implicated in various cardiovascular disorders like hypertension and
atherosclerosis by producing inflammatory markers (Hennig et al, 2002). Ang II is
also known to promote cardiovascular pathologies like atherosclerosis and AAAs
(Singh et al, 2003, Daugherty et al,1999, 2000). Mouse models infuse with Ang II
are well known biological systems used for the study of cardiovascular disorders.
Till date no studies have been conducted which link PCBs to AAAs. In this study,
we are looking at the effects of PCBs on hyperlipidemic mice models like the
LDLr -/- and ApoE -/-. The difference between the two models being the
requirement of a western diet for the induction of the cardiovascular pathology in
LDLr-/- mice.
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Previously Arsenescu et al showed that PCBs promote obesity and increase
inflammation by releasing cytokines like TNFα, MCP-1, etc (Arsenescu et al,
2008). In a separate study, Police et al showed that obesity increase in
inflammatory markers in periaortic fat which promoted the formation of AAAs
(Police et al, 2008). For this study, we hypothesized when hyperlipidemic mice
on a western/normal diet were treated with PCBs it would lead to obesity which in
turn would increase inflammation in the periaortic fat and enhance the formation
of AAAs.

SPECIFIC AIMS
AIM 1 – PCB 77 promotes atherosclerosis and AAAs in hyperlipidemic mice like
LDLr -/- and ApoE -/-.

AIM 2 – the timing of dosage of PCBs would enhance the formation of AAAs in
LDLr -/- receptor mice on a western diet.
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CHAPTER 5: MATERIAL AND METHODS

PCB 77 (3,3′,4,4′-tetrachlorobiphenyl) was obtained from Accustandard Inc.
(New Haven CT).

5.1 ANIMAL TREATMENT AND SAMPLE COLLECTION
Male LDLr-/- and ApoE-/- mice (The Jackson Laboratory, Bar Harbor, ME) at 2
months of age were housed in a pathogen-free environment. ApoE-/- mice were
fed a standard diet (Chow) and LDLr-/- mice were fed a Western diet (Table 5.1;
Table 5.2) supplemented with saturated fat (milk fat; 21% wt/wt) and cholesterol
(0.15%; wt/wt, catalog no. TD88137; Harlan Teklad). Water was provided ad
libitum. All procedures were approved by the Animal Care and Use Committee at
the University of Kentucky.
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Table 5.1 Composition of the Western Diet
(Catalog no. TD88137; Harlan Teklad)
Formula

g/kg

Casein

195

DL-Methionine

3

Sucrose

341.46

Corn Starch

150

Anhydrous Milkfat

210

Cholesterol

1.5

Cellulose

50

MineralMix,AIN-76 (170915)

35

Calcium Carbonate

4

Vitamin Mix, Teklad (40060)

10

Ethoxyquin, antioxidant

0.04

Table 5.2 Macronutrient content of the Western Diet
(Catalog no. TD88137; Harlan Teklad)
Nutrient

% by weight

% kcal

Protein

17.3

15.2

Carbohydrate

48.5

42.7

Fat

21.2

42
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5.2 STUDY DESIGN
Study 1- In this study we contrasted effects of PCB77 on Ang II-induced vascular
diseases in two different mouse models susceptible to atherosclerosis, namely
ApoE-/- and LDLR-/- mice. We chose these two strains because they are both
susceptible to Ang II-induced atherosclerosis and AAAs, but differ in the
requirement for a high fat, western diet to induce atherosclerosis. ApoE-/- mice
develop hypercholesterolemia and atherosclerosis when fed standard mouse
diet, while LDLR-/- mice require a western, high fat diet to develop
hypercholesterolemia and atherosclerosis.

For both strains, we administered

PCB77 prior to and towards the end of Ang II infusions.

The ApoE-/- mice

(n=10/group) and the LDLR-/- mice (n=10/group) were each divided equally into
two groups (Vehicle vs. Treatment). Mice were started on the respective diets
and after a week both groups were injected with PCB77 (170µM/kg; 49 mg/kg) or
vehicle (safflower oil) in volumes corresponding to the weight of each mouse (10
µL/g); the mice received PCB77 or vehicle injection prior to (2 doses), and during
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week 3 (2 doses) of AngII infusion during the 6 week study duration. Body weight
was measured weekly throughout the study. Mice from both groups were
anesthetized (ketamine/xylazine 100/10mg.Kg. ip) on week 3 for ultrasound
measurements and implantation of ALZET mini-osmotic AngII pump. Ultrasound
measurements were taken in week 5 and 6 (weeks 3 and 4 of Ang II infusion)
and blood pressure was measured during week 5 (Table 5.3). At the study end
point, mice were anesthetized with ketamine/xylazine (100/10 mg/kg ip) for blood
and tissue harvest.
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Table 5.3 Experimental Design of Study 1
Week

1

Diet

Western Diet for LDLr-/- mice and Chow diet for ApoE-/- mice

PCB/vehicle

2

3

4

5



Ang II Infusion

6

7




Ultrasound









Blood
Pressure



Body Weight

Body Weights monitored throughout the study

Table 5.4 Experimental Design of Study 2
Week

1

2

Diet
PCB/vehicle

4

5

6

Western Diet for LDLr-/- mice


Ang II Infusion
Ultrasound

3













Blood
Pressure
Body Weight


Body Weights monitored throughout the study
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7

Study 2 - This study follows the same protocol as above except this study was
conducted only in the LDLr-/- mice. (Table 5.4) The mice received all PCB77 or
vehicle injection prior to AngII infusion. This was done to see if the time of
administration of the PCB/vehicle influenced the effects of PCB77 on AngIIinduced vascular diseases. All mice were fed the western high fat diet for 1 week
prior to and then throughout Ang II infusions.

5.3 INFUSION OF ANG II
Alzet osmotic minipumps (Model 2004; ALZA Scientific Products, Mountain View,
California, USA) were implanted into LDLR-/- and ApoE–/– mice. Pumps were
filled with saline solutions of Ang II (Sigma Chemical Co., St. Louis, Missouri,
USA) that delivered (subcutaneously) 1,000 ng/min/kg of Ang II for 28 days. Mice
were anesthesized with ketamine/xylazine (100/10 mg/kg ip). A small incision
was made in the back of the neck and pumps were placed into the subcutaneous

44

space. The incision was closed with surgical staples which healed rapidly without
the need for any medication. (Daugherty et al, 2000).

5.4 DETERMINATION OF BLOOD PRESSURE
Systolic blood pressure was measured by volume pressure recording of the tail
using the VISITECH noninvasive blood pressure system on five consecutive
days in week 3 after Ang II infusion. Mice were conscious and restrained during
the procedure as described earlier in a study. (Cassis et al, 2007). At least 5
measurements were recorded from each animal and the average of the
measurements was considered.

5.5 AAA QUANTIFICATION
AAAs were quantified in vivo by measurement of maximal lumen diameters of
suprarenal abdominal aortas using high-frequency ultrasound (VisualSonics,
Vevo 660, Toronto, CA) as described previously (Barisione et al., 2006) on
anesthetized mice (ketamine/xylazine, 100/10 mg/kg, respectively, ip on day 0, 7,
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14 and day 28 of Ang II infusion). AAAs were also quantified ex vivo by
measurement of maximal width of suprarenal aortas dissected free from mice at
28 days and with extraneous tissues removed fixed in formalin by ImagePro 6
Plus 5.1 software (Media Cybernetics, Bethesda, MD). For determining the
incidence of AAAs, three observers blinded to the experimental design evaluated
the mouse AAAs in both the vehicle and treatment group.

5.6 ATHEROSCLEROSIS QUANTIFICATION
Atherosclerotic quantification was done by a procedure called en face carried out
in the mouse aortic arch which is previously described. (Daugherty et al, 2005).
To measure the extent of intimal surface covered by grossly discernible lesions,
image analysis was performed with SigmaScan (SPPS Inc., Chicago, Illinois,
USA). The percent aortic arch lesion is quantified from 3 mm down from the
subclavian arterial branch and the thoracic lesion area is quantified 9 mm further

46

down the length of the aorta. The atherosclerotic quantification is examined by
two other observers blinded to the experimental design.

5.7 MEASUREMENT OF SERUM CHOLESTEROL AND PLASMA
COMPONENTS
Serum total cholesterol and triglyceride concentrations were determined with
enzymatic assay kits (Wako Chemical Co., Richmond, Virginia, USA) as
described previously (Arsenescu et al., 2008).. At study endpoint, blood was
obtained from anesthetized mice (ketamine/xylazine 100/10 mg/kg ip) by left
ventricular puncture and collected in tubes containing EDTA (0.05 M). Plasma
was obtained by centrifugation (5,000 rpm) at 4°C for 10 min.
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5.8 STATISTICAL ANALYSIS
Data are represented as mean + SEM. Comparison of AAA incidence between
groups was analyzed using Fisher’s exact test. Unpaired Student’s t test was
used to compare parametric data between groups. One-way ANOVA was
performed to compare body weight and blood pressure data with repeated
measures on time. Analyses were performed using Graphpad Prism (Graphpad
Software Inc., San Diego, CA, USA).

Statistical significance was defined as

P<0.05.
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CHAPTER 6: RESULTS

A) STUDY 1

In this study the ApoE-/- and LDLr-/- mice received PCB77 or vehicle injection
prior to (2 doses), and during week 3 (2 doses) of AngII infusion during the 6
week study duration. ApoE-/- mice were fed standard mouse diet, while LDLR-/mice were fed a western, high fat diet.

6.A.1

PCB77 had no effect on parameters like body weight and serum

cholesterol but increased liver weights only in ApoE-/- mice and systolic blood
pressure only in LDLr-/- mice.
Earlier studies in our laboratory showed that intraperitoneal injections of low
doses of PCB77 promoted adipocyte differentiation and increased body weight
as well as increased liver weights of ApoE-/- mice (Arsenescu et al, 2008).
However in this study no difference in body weights was seen in ApoE-/- and
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LDLr-/- administered PCB77 compared to vehicle control (Table 6.1; 6.2) but a
significant increase in liver weights was seen only in ApoE-/- mice (Figure 6A.1).
Serum cholesterol concentrations were not significantly different between the
vehicle and PCB77 groups for both ApoE-/- and LDLr-/- mice (Figure 6A.2).
However, systolic blood pressure was significantly increased in LDLr-/administered PCB77 compared to vehicle, but not in ApoE-/- mice administered
PCB77 (Figure 6A.3).
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Table 6.1 Characteristics of Ang II-infused ApoE-/- mice administered vehicle or
PCB77.
Parameter

PCB77

Control

Body weight (g)

29.75+ 0.61

29.2+ 0.75

Liver weight (g)

6.52+ 0.19*

5.15+ 0.09

Cholesterol (g/dL)

327.3 + 32.8

337.9+ 51.2

Systolic blood pressure mmHg

156 + 6*

137 + 5

Data are mean + SEM from n = 8-10/group. *P<0.05 compared to control.

Table 6.2 Characteristics of Ang II-infused LDLr-/- mice administered vehicle or
PCB77.
Parameter

PCB77

Control

Body weight (g)

26.95+ 0.48

24.9+ 0.62

Liver weight (g)

5.39+ 0.26*

4.67+ 0.20

Cholesterol (g/dL)

1580+128

1461 + 71

Systolic blood pressure mmHg

144 + 3*

138 + 2

Data are mean + SEM from n = 8-10/group. *P<0.05 compared to control.
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Liver weight/Body weight %

(A)

ApoE-/-

8

*
6
4
2
0

(B)

Control

PCB

LDLr-/-

Figure 6A.1: Effect of PCB77 on liver wt/body wt % of ApoE-/- mice (A) and LDLr-/mice (B). Data are mean ± SE from 10 mice per group.*P<0.05 compared to vehicle.
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(A)

ApoE-/-

cholesterol mg/dL
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400
300
200
100
0

Control

(B)

PCB

LDLr-/-

cholesterol mg/dL

2000
1500
1000
500
0

Control

PCB

Figure 6A.2: Total Serum Cholesterol Concentrations in Control and Treated ApoE-/(A) and LDLr-/- (B) mice.
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(A)

ApoE-/Average Blood Pressure
Blood Pressure(mmHg)

150

100

(B)

50

0

Control

PCB

LDLr-/Average Blood Pressure

*

Blood Pressure(mmHg)

200
150
100
50
0

Control

PCB

Figure 6A.3: Systolic blood pressure measurements in ApoE-/- (A) and LDLr/-(B) mice administered vehicle or PCB77. Data are mean ± SE from 10 mice
per group.*Significantly different from vehicle (p < 0.05).
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6.A.2 PCB77 increases lumen and external diameters of suprarenal aortas in
ApoE-/- mice while it caused a reduction in external diameter of aortas from
LDLr-/- mice.
Aortic lumen diameters of the suprarenal aorta were measured by high resolution
ultrasound prior to Ang II infusion (baseline) and at regular intervals after Ang II
infusion (day 7, 14 and 28). An increase of 50% above the baseline lumen
diameter was considered as the formation of an aneurysm. Aortic lumen
diameter was significantly increased in the Ang II infused ApoE-/- mice
administered PCB77 (Figure 6A.4 (A), but there was no significant effect of
PCB77 on the aortic lumen diameters of LDLr-/- mice (Figure 6A.4 (C). Maximal
external diameters were measured on cleaned, excised suprarenal aortas. In
ApoE-/- mice infused with Ang II, external diameters were significantly increased
by PCB77 (Figure 6A.4 (B).

In contrast, there was a decrease in external

diameters of aortas from the LDLR-/- mice administered PCB77 (Figure 6A.4 (D).
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(A)

ApoE-/-

lumen diameter (mm)

4

*

3
2
1
0

Control

PCB

(B)

External Diameter (mm)

4

*

3
2
1
0

Control
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PCB

(C)

(D)

Figure 6A.4 Effect of PCB77 administration on lumen diameter in ApoE-/- (A) and
LDLr-/- (C) and external diameter in ApoE-/- (B) and LDLr-/- (D). Data are mean
± SE from 10 mice per group.*P<0.05 compared to vehicle.
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6.A.3

Significantly increased AAA

severity, rupture, and decreased percent

survival were observed for PCB77-treated ApoE-/- mice.
AAAs that formed in both strains of mice were examined by two observers
blinded to the experimental design. The AAAs were categorized into 4 groups
based on severity (Type I- less severe to Type IV- Rupture). PCB77 induced a
higher AAA incidence and increased aortic rupture in ApoE-/- mice. Only 60% of
mice in the PCB77 group survived while 80% of the control mice survived (Figure
6A.5).

An increase in the incidence and rupture was also observed in the PCB77
treated LDLr-/- mice but this difference was modest and not significant (Figure
6A.6).
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Figure 6A.5 AAA Incidence Severity, Rupture, and Percent Survival For PCB77treated Ang II infused ApoE-/- mice.*P<0.05 compared to vehicle
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Figure 6A.6 AAA Incidence and Percent Survival for PCB77-treated Ang II
infused LDLr-/- mice
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6. A.4 Effect of PCB77 on AngII induced Atherosclerosis in ApoE-/- and LDLr-/mice.
Ang II infusion has been described previously to augment atherosclerotic lesion
development in male ApoE–/– mice (Daugherty et al, 2000).The atherosclerotic
lesion area was determined by en face analysis of the aortic arch and thoracic
aorta. An intimal surface covered by grossly discernible lesions was determined
and is expressed as a percentage of the total intimal area. PCB77 administration
in addition to Ang II infusion significantly increased atherosclerotic lesions in the
aortic arch of ApoE-/- mice (Figure 6A.7,6A.8), but in contrast fewer
atherosclerotic lesions were seen in the LDLr-/- mice (Figure 6A.9).
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(A)

ApoE-/Aorta Arch
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*
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Figure 6A.7 Quantification of atherosclerosis in aortic arch (A) and thoracic aorta
(B) in PCB77 treated male ApoE–/– mice. Data are mean ± SE from 10 mice per
group.*P<0.05 compared to vehicle.
group.*Significantly different from vehicle (p < 0.05).
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Figure 6A.8 Intimal surface areas of aortas from Ang II infused vehicle and
PCB77 treated ApoE-/- mice. Lesions are opaque areas (white) on translucent
intimal surface.
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LDLr-/-

Figure 6A.9 Quantification of atherosclerosis in aortic arch (A) in vehicle and
PCB77 treated male LDLr–/– mice. Data are mean ± SE from 8 mice per group
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B) STUDY 2
This study was conducted only in the LDLr-/- mice. The mice received all PCB77
or vehicle injections prior to AngII infusion.

6.B.1 PCB77 had no effect on body weight and serum cholesterol but
significantly increased systolic blood pressure in LDLr-/- mice infused with Ang II.
LDLr-/- mice treated with PCB77 prior to Ang II infusion did not show any effect
on body weights and serum cholesterol (Figure 6B.1) similar to study 1. Also
these PCB77 treated LDLr-/- mice had a significantly increased systolic blood
pressure (Figure 6B.2) similar to findings in study 1. Hence the timing of the PCB
injections had similar effects on the blood pressure in both the studies.
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Figure 6B.1 Total serum cholesterol concentrations in control and PCB77-treated
LDLr-/- mice.

Figure 6B.2 Systolic blood pressure measurements of LDLr-/- mice administered
vehicle or PCB77. Data are mean ± SE from 10 mice per group.*P<-0.05
compared to vehicle.
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6. B.2 PCB77 significantly decreased the external diameter of suprarenal aortas
from Ang II infused LDLr-/- mice.

Aortic lumen diameters remained unaffected when LDLr-/- mice were treated with
PCB77 prior to Ang II infusion (Figure 6B.3A). Surprisingly, the external aortic
diameter was significantly decreased in Ang II infused LDLr-/- administered
PCB77 compared to control (Figure 6B.3B).
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(A)

(B)

Figure 6B.3 Effect of PCB77 administration when given prior to Ang II infusions
on lumen diameter (A) and external diameter (B) of suprarenal aortas from LDLr/- mice. Data are mean ± SE from 10 mice per group.*P<0.05 compared to
control.
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6. B.3 Increase in atherosclerotic lesion formation was observed when compared
to the previous study in PCB77 treated Ang II infused LDLr-/- mice.
In contrast to findings from study 1, when administered prior to infusions of Ang
II, PCB77 resulted in a profound increase in atherosclerotic lesion formation in
the aortic arch though the difference was not significant (Figure 6B.4).
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(A)

(B)

Figure 6B.4 Quantification of atherosclerosis in aortic arch (A) and thoracic aorta
(B) in vehicle and PCB77 treated male LDLr–/– mice. Data are mean ± SE from 8
mice per group.
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CHAPTER 7: DISCUSSION
In this study we examined the effects of coplanar PCB77 on Ang II induced
vascular diseases including atherosclerosis and AAAs in two different
hyperlipidemic mouse strains, ApoE-/- and LDLr-/- mice. The timing interval of
PCB77 administration was also examined in LDLr-/- mice. Results demonstrated
that when PCB77 was administered prior to and during Ang II infusions in ApoE/- mice it increased systolic blood pressure, aortic lumen diameters and external
diameters of AAAs, and also increased the severity, rupture and incidence of
AAAs. Also profound atherosclerotic lesions were seen in the ApoE-/- mice
administered PCB77. No effect of PCB77 was observed on body weight and
serum cholesterol in either mouse strain. In study 2, when PCB77 was
administered prior to Ang II infusion in LDLr-/- mice, the results demonstrated
increase in liver weights. Moreover, systolic blood pressure was increased in
LDLr-/- mice regardless of the timing of PCB77 administration. However, in
contrast to results from study 1, PCB77 administration prior to infusions of AngII
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unexpectedly reduced AAA incidence and size.

Our results suggest that

background strain, use of high fat diets, and timing of PCB77 administration in
reference to infusions of AngII influences the development of atherosclerosis and
AAAs.

Ang II, the most important effector molecule of the RAS, plays a role in the
pathophysiology of vascular disorders like atherosclerosis and AAAs. Previous
studies show when Ang II is infused in hyperlipidemic mice like ApoE-/- and
LDLr-/- mice at a higher dose of 1000ng/kg/min for 28days it leads to
development of atherosclerosis and AAAs (Daugherty et al, 2000). Hence these
mice serve as good models to study Ang II induced vascular diseases. A major
difference between these mouse strains is the requirement of consumption of a
western diet in LDLr-/- mice, but not in ApoE-/- mice, to induce atherosclerotic
lesion formation. Hence nutrient composition of the diets used in this study was
one variable under study in defining effects of PCB77. Also PCB77 being
lipophilic in nature was probably getting sequestered in the adipose tissue in
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mice that were fed with the western diet, which could be a possible reason for the
varied results seen between the two mouse models based on the nutrient
composition of the diets.

Coplanar PCBs also known as dioxin like compounds are AHR agonists. Due to
being persistent in nature, they were banned in United States in 1977. These
compounds are yet found in all parts of the global ecosystem along with
substances like food, breast milk, oily fish etc. Evidence shows that PCBs are
proinflammatory and are implicated in a number of cardiovascular diseases
especially hypertension and atherosclerosis. Earlier experiments in our
laboratory demonstrated that PCB77 caused notable atherosclerotic lesions in
the aortic arch (Arsenescu et al 2008).

Evidence from previous studies show that PCBs at a higher dose mimic effects of
the wasting syndrome and also cause weight loss. Hence for the present study
PCB dosage was similar to the earlier studies in our laboratory (four injections of
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49mg/kg per dose in 6 weeks of study duration) (Arsenescu et al, 2008). This
dosage has shown to produce proinflammatory effects on endothelial cells
(Toborek et al, 1995) and adipocytes (Arsenescu et al 2008) when injected in
mice. Also this dose is considered as moderate exposure in experimental
animals. (Sipka et al, 2008)

To the best of our knowledge this is the first study that examines the effect of
coplanar PCBs on Ang II induced vascular disorders especially AAAs. PCBs are
shown to promote adipocyte differentiation and inflammatory gene expression in
adipocytes. (Arsenescu et al, 2008) In a separate independent study in our lab
(Police et al, 2009) results showed that the type of adipocytes surrounding aortic
regions and the ability of white adipocytes to recruit macrophages may localize
AAAs to abdominal aortas of AngII-infused mice. Hence we hypothesized that
PCBs promote obesity causing adipocyte differentiation which by recruitment of
macrophages influence the formation of AAAs in Ang II infused mice.
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PCB77 administration along with AngII infusion caused a significant increase in
the lumen diameter and external aortic diameter in the ApoE-/- mice but not in
the LDLr-/- mice. Surprisingly even when the timing interval of PCB77
administration was altered instead of an increase in AAA formation a significant
decrease in external aortic diameter was observed. This may be due to the
lipophilic nature of the PCB77. The western diet, which causes an increase in the
adipose mass, maybe sequestering the PCBs and preventing them from further
accentuating the AAA formation.

Surprisingly in the present study no effect was seen on body weight in both PCB
treated ApoE-/- and LDLr-/- mice. No changes were seen on average body
weights between control and PCB treated mice. Ang II causes weight loss in rats
in a pressor independent mechanism (Brink et al, 1996). This weight loss is due
to reduced caloric intake or maybe due to an added metabolic effect. We did not
observe weight gain or loss in mice infused with AngII and administered PCB77,
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suggesting that effects of PCB77 (increase body weight) and Ang II infusions
(decrease body weight) may have been counterbalanced.

Previous investigators have shown that PCBs increase hepatic cholesterol
synthesis which results in hypercholesterolemia in rats (Nakagawa et al, 1986).
In the present study, in the PCB treated ApoE-/- mice as well as LDLr-/- mice did
not show any changes in total serum cholesterol concentrations despite of being
on a high fat Western diet. This may be due to Ang II infusion influencing the
effect of PCB77. Also in the LDLr-/- mice this lack of effect would be dietary
interactions between the high fat diet and PCBs. PCBs being highly lipophilic and
may get sequestered in the high fat diet, resulting in an absence of effect. It is
also possible that LDLr-/- mice that are fed on a high fat diet have serum
cholesterol concentrations that are very high producing a saturating effect for
PCBs to induce any further changes in these levels.
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Both Mouse models also exhibited modifications in liver weights in the PCB
treated group. In the past Hennig and coworkers have shown that when wild type
mice were fed a high fat diet (40% linoleic acid) and exposed to PCB77 there
was a significant increase in liver-to-body weight ratio (Hennig et al, 2005).
Earlier studies have also shown that rats fed a high fat diet can induce
hepatotoxic responses to PCB77 and PCB153 including lipid peroxidation and
hepatomegaly (Fadhel et al, 2002). Hence this study extends the findings of the
previous studies.

PCB77 caused an increase in systolic blood pressure in LDLr-/- as well as ApoE
-/- mice. AHR ligand 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) increased blood
pressure in adult male C57BL/6 mice when dosed with vehicle or 300 ng
TCDD/kg by oral gavage three times per week for 60 days (Kopf et al., 2008).
Earlier studies have also shown that AHR null mice developed cardiac
hypertrophy and elevated mean arterial pressure due to increased levels of
systemic Ang II and ET-1. (Zhang et al, 2010) Similar results were demonstrated

77

in studies by other investigators where AHR deficient mice at modest altitude
(1632m) demonstrated increase in mean arterial pressure that was associated
with increased systemic concentrations of AngII (Lund et al., 2003; Lund et al.,
2008). However, in later studies by this group results indicated that AHR null
mice are hypotensive at low altitude (225m) and blockage of the RAS showed
minimal blood pressure control,

suggesting normal blood pressure in

heterozygous AHR (+/-) mice appears to be maintained by increased RAS, while
hypotension in null AHR (-/-) mice may result from decreased RAS signaling
(Zhang et al, 2010; Lund et al 2008). Result from this study supports these earlier
studies indicating that exposure to an AHR ligand PCB77 caused elevations in
systolic blood pressure after infusion with Ang II. Although earlier studies in our
lab (Cassis et al, 2009) have demonstrated that Ang II mediated elevation in
blood pressure is not implicated in Ang II induced atherosclerosis and AAAs.
Hence it can be summarized that even though exposure to PCB 77 causes an
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increase in systolic blood pressure that in turn would not induce Ang II mediated
vascular disorders.

An increase in atherosclerotic lesion formation in the aortic arch was observed in
ApoE-/- mice and LDLr-/- though more marked effects were observed in ApoE-/mice. A number of studies indicate that coplanar PCBs play a role in
atherosclerotic lesion formation either by endothelial dysfunction, oxidative
stress, inflammatory cytokine expression (Toborek et al, 1995; Hennig et al,
2002) and increased lesion formation in ApoE-/- mice (Arsenescu et al, 2008).
Coplanar PCBs (PCB 77 and PCB 114) significantly disrupt endothelial barrier
function by allowing an increase in albumin transfer across endothelial
monolayers and also cause cellular oxidative stress (Toborek et al 1995).
Exposure to coplanar PCBs also increased the expression of inflammatory
cytokines like cytochrome 450, VCAM-1, IL-6 etc. (Toborek et al, 1995; Hennig et
al, 2002) and induced expression of VCAM in aortas of mice. (Hans et al, 2010).
Ang II is also known to show similar effects and has been implicated in promoting

79

vascular disorders like atherosclerotic lesion formation. Hence the results of the
present study indicates that exposure to PCB77 along with infusion of Ang II may
have an additive effect to increase atherogenic lesion formation.

Also the lack of effect in the LDLR-/- mice after PCB injections were administered
prior to Ang II infusion maybe due to feedback inhibition that may have occurred
due to increased production of cyp1A1, cyp1A2 and cyp1B1. When PCBs were
administered all together this increased the levels of these cytochrome P450’s
and they in turned inhibited their transcription blunting the effect of PCBs in these
mice.

Exposure to PCB77 influenced the formation of AAAs increasing the severity and
rupture in both mice models. The timing interval of PCB administration failed to
see a profound effect on AAA development, surprisingly a significant decrease in
external aortic diameter was seen but increased percent atherosclerotic lesion
development in LDLr-/- mice. PCB77 primarily promoted more severe AAAs, with
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increased aortic rupture in both mouse models. These effects of PCB77 were
more pronounced when PCB77 was administered during AngII infusions
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CHAPTER 8: CONCLUSION
In conclusion, at low exposure levels coplanar PCB77 promoted the formation of
Ang II induced vascular disorders namely atherosclerosis and abdominal aortic
aneurysms in two hyperlipidemic mouse strains, ApoE-/- and LDLr-/- mice. The
timing interval for PCB administration played a pivotal role in seeing profound
effects on these vascular conditions. Peripheral parameters like body weights
and serum cholesterol concentrations were not affected in ApoE-/- mice and
LDLr-/- mice. In spite of no changes in cholesterol levels, systolic blood pressure
was markedly increased in ApoE-/- mice as well as in LDLr-/- mice despite of the
timing of PCB administration. Incidence of AAAs, severity and rupture of AAAs
were evident in both mouse strains but were dependent on the timing of the PCB
injections in LDLr-/- mice. These results suggest that the timing of PCB77
administration, in addition to dietary interactions, influence PCB77 augmentation
of AngII-induced vascular diseases. Studies focusing on the mechanisms by
which the timing of PCB77 administration influences the ability of PCB77 to
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promote vascular diseases would be beneficial in shedding some light to these
results. Also treatment that involves minimizing or limiting exposure to PCBs
would be beneficial in reducing the incidence of these vascular disorders.
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